Sulphasalazien and lung toxicity

European Respiratory Journal

Volumn 19, Issue 4, 2002, Pages 756-764

  Parry, S D ^a   Barbatzas, C ^a   Peel, E T ^a   Barton, J R ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Adverse drug reaction lung; Pulmonary disease; Sulphasalazine

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; IBUPROFEN; METHOTREXATE; SALAZOSULFAPYRIDINE; SULFONAMIDE; ANTIRHEUMATIC AGENT;

ADOLESCENT; ADULT; AGED; ALLERGY; BLOOD DYSCRASIA; CONTROLLED STUDY; COUGHING; DATA BASE; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; DYSPNEA; EOSINOPHILIA; FEMALE; FEVER; HUMAN; LUNG AUSCULTATION; LUNG FIBROSIS; LUNG INFILTRATE; LUNG TOXICITY; MALE; MEDICAL LITERATURE; MEDLINE; PRESCRIPTION; PRIORITY JOURNAL; RASH; REVIEW; SCHOOL CHILD; SPUTUM; THORAX PAIN; THORAX RADIOGRAPHY; ULCERATIVE COLITIS; WEIGHT REDUCTION; CHEMICALLY INDUCED DISORDER; ENTERITIS; LUNG DISEASE; MIDDLE AGED;

ANTIRHEUMATIC AGENTS; COLITIS, ULCERATIVE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LUNG DISEASES; MALE; MIDDLE AGED; SULFASALAZINE;

EID: 0036009592     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.02.00267402     Document Type: Review

References (84)

1. Sulfasalazine in rheumatoid arthritis. A double-blind, placebo-controlled trial
2. Combination therapy in early rheumatoid arthritis: A randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components
3. Therapeutic approaches for early rheumatoid arthritis. How early? How aggressive?
4. Adverse reactions to salicylazosulfa-pyridine (azulfidine) in the treatment of ulcerative colitis
5. Sulphasalazine-induced lung disease
6. Respiratory disease induced by drugs
7. Drugs that may injure the respiratory system
8. Weekly clinicopathological exercises. Case 12-1993. A 44-year old man with pulmonary disease and proctitis
9. Salazopyrin-induced eosinophilic pneumonia
10. Fibrosing alveolitis and treatment with sulphasalazine
11. Sulphasalazine-induced reversible hypersensitivity pneumonitis and fatal fibrosing alveolitis: Report of two cases
12. Sulfasalazine-induced pulmonary disease
13. Interstitial pneumonia due to sulfasalazine
14. Pathological changes in lungs and liver after therapy of ulcerative colitis
15. Fibrosing alveolitis, bronchiolitis obliterans, and sulfasalazine therapy
16. Salazosulfapyridine-induced eosinophilic pneumonia with pulmonary and cutaneous epithelioid cell granulomatosis in Sjogren syndrome
17. Sulfasalazine-induced pulmonary disease
18. Sulfasalazine lung. Desensitization to sulfasalazine and treatment with acrylic coated 5-ASA and azodisalicylate
19. Sulphasalazine lung
20. Pulmonary infiltrates and eosinophilia associated with sulfasalazine
21. Pulmonary infiltration and eosinophilia associated with sulfasalazine therapy for ulcerative colitis: A case report and review of literature
22. Time course of recovery of lung function in sulphasalazine-induced alveolitis
23. Sulfasalazine pulmonary toxicity in ulcerative colitis mimicking clinical features of Wegener's granulomatosis
24. Bronchoalveolar lavage in acute hypersensitivity pneumonitis caused by sulfasalazine
25. Eosinophil pleuritis induced by salazosulfapyridine
26. Respiratory disease due to sulphasalazine
27. Sulphasalazine-induced eosinophilic pneumonia
28. Pulmonary infiltrates and eosinophilia associated with sulphasalazine administration
29. Lung manifestations after salazopyrinine intake
30. Olsalazine as an alternative therapy in a patient with sulfasalazine-induced eosinophilic pneumonia
31. Reversible pulmonary disease and eosinophilia associated with sulphasalazine
32. Drug-induced alveolitis caused by salazosulfapyridine
33. Sulfasalazine and pulmonary infiltrates
34. Acute alveolitis and sulphasalazine in rheumatoid arthritis
35. Sulphasalazine induced lung disease
36. Sulfasalazine pneumonitis
37. Salazopyrin-induced eosinophilic pneumonia
38. Salazosulfapyridine-induced lung disease
39. Eosinophilic pneumonia: An unusual side effect of therapy with salicylazosulfapyridine
40. Sulphasalazine-induced sub-acute hyper-sensitivity pneumonitis
41. Pneumonitis induced by sulphasalazine
42. Sulfasalazine-induced lupus erythematosus
43. Pulmonary disease induced by salazopyrine coexisting with pulmonary tuberculosis
44. Reversible pulmonary disease and eosinophilia associated with sulphasalazine
45. Severe interstitial pulmonary fibrosis in a patient with chronic ulcerative colitis
46. Desquamative interstitial pneumonitis complicating inflammatory bowel disease of childhood
47. Radiographic changes in the chest in a patient with ulcerative colitis treated with salazosulfapyridine
48. Fibrosing alveolitis due to sulphasalazine in a patient with rheumatoid arthritis
49. Pulmonary infiltrates and skin pigmentation associated with sulfasalazine
50. Salazosulfapyridine responsible of eosinophilic pneumonia
51. Pneumopathy due to sulfasalazopyrine. A case with a challenge test
52. A case of severe reversible lung disease caused by sulphasalazine
53. Sulfasalazine pneumonitis
54. A new case of hypersensitivity pneumopathy caused by salazopyrine?
55. Immuno-allergic pneumopathy to salazosulfapyridine during ulcerative colitis
56. Hypersensitivity pneumonitis by sulphasalazine
57. Methotrexate pulmonary toxicity
58. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: A multicenter study with literature review
59. A case of eosinophilic pneumonia and vasculitis induced by diflunisal
60. Rash and pulmonary eosinophilia associated with fenbufen
61. Drug-induced pulmonary edema in a patient infected with human immunodeficiency virus
62. Morphology and pathogenesis of desquamative interstitial pneumonitis
63. Transient pulmonary eosinophilia and asthma. A review of 20 cases occurring in 5,702 asthma sufferers
64. Salicylate-induced pulmonary edema. Clinical features and prognosis
65. Alveolitis associated with sulphamethoxypyridazine
66. Pneumonitis caused by mesalazine
67. Are there characteristic alterations in lung tissue associated with Crohn's disease?
68. Crohn's disease of the lung
69. Bronchiectasis with ulcerative colitis and myelopathy
70. Bronchial disease in ulcerative colitis
71. Bronchiolitis obliterans organising pneumonia in a patient with ulcerative colitis
72. Pulmonary vasculitis-an uncommon complication of ulcerative colitis. Report of a case
73. The epidemiologic and demographic characteristics of inflammatory bowel disease: An analysis of a computerized file of 1400 patients
74. Ulcerative colitis and steroid-responsive, diffuse interstitial lung disease. A trial of n=1
75. Pulmonary vasculitis complicating ulcerative colitis
76. Unexplained bronchopulmonary disease with inflammatory bowel disease
77. Chronic bronchial suppuration and inflammatory bowel disease
78. The lung in inflammatory bowel disease
79. Large airway disease associated with inflammatory bowel disease
80. Pathogenetic and clinical relevance of cytokines in inflammatory bowel disease
81. Pulmonary function in patients with inflammatory bowel disease
82. Respiratory impairment in inflammatory bowel disease does it vary with disease activity?
83. Thoracoscopy versus open lung biopsy in the diagnosis of interstitial lung disease: A randomised controlled trial
84. Videothoracoscopy versus thoracotomy in the diagnosis of diffuse interstitial disease